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Abstract:  
BACKGROUND: Levonorgestrel-releasing intrauterine system (LNG-IUS), although inserted to reduce heavy 
menstruation, causes irregular early transient bleeding. The objective of the study was to document quantitative 
changes in endometrial vessels of short- (<3 months) and long-term (>12 months) LNG users. The area, density 
and maturation of endometrial vessels were quantified in 19 endometrial biopsies of women with LNG-IUS and 
in 10 normally ovulating patients during mid-luteal phase.  
METHODS: Vessel maturation was evaluated by double immunostaining using anti-von Willebrand factor 
(endothelial cell marker) and anti-alpha Smooth Muscle Actin (vascular smooth muscle cells) antibodies. Vessel 
area, number and density were quantified with a novel computer-assisted image analysis system.  
RESULTS: Endometrium exposed to LNG-IUS for 1-3 months displayed a 11.5-fold increase in small naked 
vessel number. The partially mature vessel (αSMA partially positive) number increased six times. After long-
term LNG-IUS treatment, the immature and partially mature vessel number remained four times higher than in 
the control group. Vessel area and density also increased dramatically in a time-dependent pattern with LNG-
IUS use.  
CONCLUSIONS: Levonorgestrel affects blood vessel number, area, density and maturation in a time-dependent 
pattern that may explain the early transient increase in breakthrough bleeding with the LNG-IUS. 
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INTRODUCTION 
Long-term progestin-only contraceptive methods such as the levonorgestrel-releasing intrauterine system (LNG-
IUS) lead to irregular and abnormal endometrial spotting and bleeding. This unpredictable breakthrough 
bleeding (BTB), which causes considerable social discomfort and reduces quality of life, is the most common 
reason for discontinuation of use in ~25% of women (Vekemans, 1995; Vekemans et al, 1997). It occurs 
predominantly during the first few months of treatment and then progressively and spontaneously decreases. 
The exact mechanism responsible for these bleedings is unknown and the aetiology seems to be multifactorial. 
Several studies have demonstrated a possible contribution of matrix metalloproteinases (MMPs) (Skinner et al., 
1999; Vincent et al., 1999; Galant et al., 2000; Vincent et al., 2002; Chegini et al., 2003; Galant et al., 2004), 
tissue factor (TF) (Runic et al., 2000) and granulocyte-macrophage cytokines (Critchley et al., 1998). Anomalies 
in progesterone and estrogen receptor expression have been also shown to play a role in BTB associated with 
LNG-IUS (Critchley et al., 1998; Zhu et al., 1999). 
Modifications in endometrial microvascular density and a decrease in vessel maturation due to a lack of 
surrounding pericytes and smooth muscle cells may also be involved in this process along with modifications of 
endothelial basement membrane structure and composition (Rogers et al., 1993; Hickey et al., 1999; Jondet et 
al., 2005). Following Norplant exposure, a reduction of basement membrane components around the endometrial 
endothelium has been demonstrated but without any correlation with bleeding episodes (Hickey et al., 1999). 
In order to determine the extent of vascular remodelling in endometrium of women exposed to LNG-IUS, we 
compared, in this study, the area, density and maturation of blood vessels after short- or long-term exposure to 
LNG-IUS. 
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MATERIALS AND METHODS 
Patients 
The study was approved by the Ethical Committee of the University Hospital. Nineteen endometrial biopsies 
were analysed. Eight biopsies (Group I) were obtained from women exposed to LNG-IUS (Mirena®, Bayer 
Schering Pharma, Berlin, Germany) for a period of 1-3 months. In fact, these eight women (mean age 39 years 
old), with an indication of hysterectomy for benign gynaecological indication, were prospectively recruited. 
Written informed consent was obtained from each woman and LNG-IUS was inserted into each subject for a 
median period of 1 month prior to surgery. Eleven biopsies (Group II) were obtained from women with 
breakthrough bleeding (mean duration of exposure 36 months, range 12-60 months) who required LNG-IUS 
removal for pregnancy desire or LNG-IUS change. Biopsies were retrieved from the Department of 
Anatomopathology, University Hospital, Liège, Belgium. 
The control group consisted of 10 endometrial biopsies, performed during the mid-secretory phase of a 
spontaneous documented ovulatory cycle of women with documented fertility. The ages of the women in each 
group are shown in Table 1. All women in both LNG-IUS groups had presented at least one episode of transient 
bleeding during the 2 weeks prior to biopsy, whereas no breakthrough bleeding was observed in women with 
ovulatory cycles. 
Table I: Patients' distribution in short-term LNG, long-term LNG and control groups. 







Patients, n 10 8 11 
Age, Mean ± SD 33.1 ± 3.1 39.2 ± 5.7 41.7 ± 7.4 
Endometrial tissues 
All biopsies were obtained with a Cornier Pipelle suction curette (C.C.D. International, Paris, France) that allows 
sampling of the functional layer of the endometrium. Tissue were fixed in 4% formaldehyde solution in 
phosphate buffer saline (PBS) and embedded in paraffin. Specimens obtained during the mid-secretory phase 
were classified according to classical criteria (Noyes et al., 1950). 
Von Willebrand factor/ α-smooth muscle actin double immunostaining 
Serial sections (5 µm) were mounted on silanized slides and used for immunochemistry. The endometrial 
vasculature was visualized by double immunostaining of endothelial cells and perivascular cells. The primary 
antibodies (Abs) used were a rabbit polyclonal anti-human von Willebrand factor (vWF, A082, Dako, Denmark) 
and a mouse monoclonal anti-alpha smooth muscle actin (αSMA, clone 1A4, A2547, Sigma-aldrich, USA). 
Slides were washed in Tris-HC1, pH 7.6 between all steps unless otherwise stated. Endogenous peroxidase was 
blocked with 3% H2O2 for 20 min at room temperature (RT). Slides were incubated with normal sheep serum 
(NSS) (Hormonology laboratory, Marloie, Belgium) for 30 min at RT, directly followed by vWF Ab (1/500 in 
NSS/Tris 10%) overnight at 4°C A swine anti-rabbit immunoglobulin conjugated to peroxidase (P0217, Dako, 
Denmark) was used as a secondary Ab. DAB + (Liquid DAB+ substrate chromogen system, K3468, Dako, 
Denmark) was applied for 15 min at RT in the dark as a chromogen and sections were rinsed in H2O. Slides were 
incubated with normal goat serum (NGS) (Hormonology laboratory, Marloie, Belgium) before being incubated 
with the second primary Ab, αSMA (1/400 in NGS/Tris 10%) for 90 min at 37°C. A goat anti-mouse Ab 
conjugated to biotin (E 0433, Dako, Denmark) diluted 1/400 in Tris buffer for 30 min at RT was used as a 
secondary Ab, followed by an incubation for 30 min at RT with streptavidine-alkaline phosphatase (D 0396, 
Dako, Denmark) diluted 1/500. Finally, Fast Red chromogen system (K4016, Dako, Denmark) was applied for 
10 min at RT in the dark. Sections were rinsed in H2O and mounted in Aqua Polymount (Polysciences, Inc., 
Warrington, PA, USA). Negative controls were performed by replacing each primary Ab with normal serum. 
Myosin heavy chain staining 
Serial sections were stained either with αSMA or myosin heavy chain (MHC) Abs in order to compare the 
relative distribution, and to quantify the proportion, of αSMA positive vessel sections that also reacted with the 
anti-MHC Ab. 
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The MHC was visualized by the following steps. First, slides were incubated with proteinase K (50 µg/ml) 
diluted in Tris-HCl for 10 min at 37°C, and then slides were heated in a microwave oven set at 1.4 bar and 
126°C for 11 min in target retrieval buffer (M3558, DAKO, Denmark). Endogenous peroxidase was blocked in 
3% H2O2 for 20 min at RT, and an incubation with mouse anti-human MHC Ab (M3558, DAKO, Denmark) 
diluted 1/100 was conducted 60 min at RT. Sections were washed in PBS (5x5 min) before incubation with the 
appropriate secondary Ab (goat anti-mouse, P0217, DAKO, Denmark) conjugated to biotin diluted 1/400, for 30 
min, at RT. Finally, sections were incubated for 30 min with Streptavidine conjugated to HRP, diluted 1/500 for 
30 min at RT and staining was revealed with the DAB system. 
Staining of the argyrophilic fibrillar network 
Silver impregnation of histological sections was performed as previously described (Gordon and Sweets, 1936). 
Image analysis and measurement 
Slides were observed with an Olympus microscope (Omnilabo, Aartselaar, Belgium) and the entire section 
[mean area 78.73 mm (range 22.90-163.07 mm2)] was analysed at magnification of x400 by two observators 
(S.L. and S.R.). As described by Rogers et al. (2000), a score (0, 1 or 2) was attributed to blood vessels 
according to the intensity of αSMA staining. A score of 0 represents absence of αSMA, score 1 represents 
irregular αSMA distribution around part of the vessel circumference and score 2 indicates a positive continuous 
staining of the entire vessel circumference (Fig. 1). The entire endometrial tissue sections were analysed by 
counting vessels in 20-100 consecutive fields covering the entire endometrial area. 
The contour of each vessel type was drawn manually at x 400 magnification using Photoshop software by three 
different colours: turquoise for score 0, blue for score 1, red for score 2 and green for tissue boundaries (Fig. 
2A). Then, the colour image was decomposed into its three components: red (R), green (G) and blue (B) (Russ, 
1999a and b). For example, in R image, components corresponding to vessels scored 2 were strongly contrasted. 
Each of the R, G and B image component was therefore processed independently in order to obtain a binary 
image in which pixels belonging to vessels were attributed a value 1 (white) and pixels belonging to the 
background were attributed a null value (black). Figure 2B-D shows binary images of vessels scored 0, 1 and 2, 
respectively. 
For each binary image, the following parameters were determined: number of vessel sections, vessel area (µm2) 
and tissue area (µm2). Image processing and measurements were performed with the software Aphelion 3.2 from 
Adsis (France) on a PC. 
Figure 1: Illustration of αSMA immunostaining scoring. αSMA positive cells were labelled in red and 
endothelial cells were stained in brown with an anti-vWF Ab. (A) Score 0 vessels are αSMA negative, (B) score 1 
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Figure 2: Image analysis and vessel quantification. (A) The contour of each type of vessel was drawn manually 
in the original image by the following different colours: turquoise for vessels scored 0, blue for vessels scored 1 
and red for vessels scored 2. Green delineates the area of tissue in which measurements are performed. (B) 
Binary images of score 0 vessels, (C) binary image of score 1 vessels and (D) binary image of score 2 vessels 
contained in the original image 
 
Statistic analysis 
The number and area of vessels, as well as the corresponding area of tissue measured on each image, were 
analysed in the following two different ways: (i) vessel number per unit of tissue area (n/mm2) and relative 
vascular area defined as the proportion of tissue area occupied by the vessels (%) were calculated for each image 
individually. Then, the mean value of these parameters was determined for each patient. Finally, the mean + 
SEM vessel number per unit of tissue area and the relative vascular area for all patients of the same group were 
determined, (ii) The vessel number per unit of tissue area and the relative vascular area were calculated for each 
patient. To do this, the number (or the area) of vessels measured on all five images of a patient were added and 
divided by the sum of the area of the tissue in the same five images. This gives only one value of the vessel 
number per unit of tissue area and of the relative vascular area by patient. Finally, the mean + SEM of those 
parameters was calculated for all the patients of the same group. As the area of the tissue considered on each 
image was not the same, the two calculations do not coincide exactly but follow closely the same trends, which 
suggest that the spatial distribution of vessels is rather homogeneous. Then, for the sake of simplicity, only the 
results obtained with the first method are discussed in the present paper. Relative vascular area and relative 
vessel number were represented as a percentage for each vessel category, calculated from values determined 
according to the method (i). 
Analyses for statistical significance were evaluated with non-parametric methods. Kruskal-Wallis test with 
Dunn's correction for multiple comparisons was first applied. Then, for the cases in which significant differences 
were found between two groups, Mann-Whitney U-test was used to confirm this difference. Statistical 
significance was set at P < 0.05. 
RESULTS 
Stromal breakdown and fiber lysis 
Stromal breakdown occurring in women with endometrial breakthrough bleeding (BTB) (Galant et al., 2000; 
Kokorine et al., 1996) was documented by staining of argyrophilic fibrillar network using silver impregnation. 
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Focal lysis of the collagen-rich fibrillar network was observed in all biopsies obtained after LNG-IUS use in the 
short- and long-term LNG groups but in none of those obtained from the control group (Fig. 3). This was 
consistent with the mild bleeding reported by women incorporated in the study. The area of stromal breakdown 
represented <5% of total tissue area. The mean number of vessel sections/mm in such areas was reduced by 40-
70% (data not shown). Therefore all subsequent evaluation of vessel characteristics was performed in intact 
zones. 
Vessel characterisation 
Three types of endometrial vessels were identified by double vWF-αSMA immunostaining. (i) Vascular 
endothelial cells that react with the anti-human vWF were the only cell types in some vessels (Fig. 1A—Score 
0). (ii) Vessels coated with a discontinuous layer of pericytes identified by their αSMA content (Fig. 1B—Score 
1). (iii) A continuous layer of αSMA positive cells surrounded by another fraction of vessel sections (Fig. 1C—
Score 2). 
In addition, we compared distribution of αSMA and MHC in vascular pericytes, since the former is a marker of 
smooth muscle cell differentiation, although the presence of myosin correlates with a functional contractile 
competence of vessels (Rogers and Abberton, 2003; Abberton et al., 1999). Myosin distribution closely 
correlates with αSMA pattern in endometrial vessels of the three groups (Fig. 4A). Quantitative evaluation 
indicated that ~70% of vessels coated with pericytes (αSMA positive) also contained myosin and were 
contractile (Fig. 4B). This percentage was identical among the three groups of women. 
Figure 3: Focal stromal breakdown and lysis of the collagen-rich argyrophilic fibrillar network observed using 
silver impregnation. Control group (A) short-term LNG group (delimitated zone) (B) and long-term LNG group 
(delimitated zone) (C) Original magnification x 100 
 
The number of vessel sections is increased in endometrium of LNG-IUS users 
The number of vessel sections per mm was counted by a novel computer assisted method from binary structure 
after image transformation. In total, 11093 vessel sections were counted for the three groups (Fig. 5). A 
statistically significant increase in vessel section number of immature (11.5x) (P = 0.0002) and partially mature 
(6x) (P = 0.0018) vessels was observed in short-term treated patients (Group I) compared with control group. 
Less dramatic was the increase in the number of immature (4x) (P = 0.004) and partially mature (4 x ) (P = 
0.001) vessels observed after long-term LNG-IUS use (Group II) compared with control group (Fig. 5). The 
vessel section number of mature vessels/mm was significantly decreased after short- or long-term exposure to 
LNG (P < 0.0001) compared with the control group (Fig. 5). Comparison between the long- and short-term LNG 
groups shows an increased vascularization in short-term LNG users, which is mainly associated with the 
development of naked vessels. The number of vessel sections of partially mature and mature vessels was not 
different between the short and long duration of LNG-IUS treatment. 
The relative vascular area is increased in endometrium from women treated with levonorgestrel 
The relative vascular area, corresponding to the ratio of vessel surface to the total tissue area, was significantly 
increased in endometrium of LNG users (Group I and II) when compared with the control group. This significant 
increase was observed for naked (pericytes-free) vessels scored 0 in the short-term LNG group (P < 0.0001) and 
long-term LNG group (P = 0.0015). The relative vascular area of mature vessels decreased in short-term LNG 
group when compared with the control (P < 0.0001) and long-term LNG groups (P = 0.0002) (Fig. 6A). 
The duration of LNG exposure also dramatically influenced the extent of vascularization and vessel maturation. 
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Although αSMA-coated vessels (score 2) were the most prevalent vessels in control group, short-term exposure 
to LNG-IUS caused a 4-fold increase of naked (αSMA negative) vessel area. The relative vascular area of these 
immature vessels became the predominant vessel type, whereas partially mature and mature vesseled areas 
became less prevalent after 1 month of treatment. This change in the pattern of endometrial vascularization in 
short-term treatment could promote vessel leakage and rupture and may explain the transient unwanted spotting 
and bleeding frequently reported after short-term LNG use. After prolonged treatment, the relative vessel area of 
naked vessels (score 0) decreased in comparison with that in short-term users (Fig. 6A). 
Figure 4: Staining of αSMA (a,c,e) and MHC (b,d,f) on serial sections in Control group (a,b), short-term LNG 
group (c,d) and long-term LNG group (e,f). (A) Original magnification x200. (B) Ratio of number vessel sections 
with positive MHC staining on total number of vessel sections with positive αSMA staining in Control group (n = 
10), short-term LNG group (n = 8) and long-term LNG group (n= 11) 
 
The degree of vessel maturity was different among the three groups. The percentage of the total vascular area 
occupied by immature vessels (devoid of pericytes) was considerably higher in short-term LNG-IUS users 
(Group I) than in control group (P < 0.0001) (Fig. 6B). No difference was shown in the proportion of total 
vascular area occupied by partially mature vessels (score 1) between the three groups. A significant decrease was 
observed in the proportion of mature vessels (score 2) in the short-term LNG group when compared with the 
control group (P < 0.0001) or the long-term LNG group (P = 0.0002) (Fig. 6B). 
Vessel area varies according to the duration of treatment with LNG-IUS 
The mean vessel surfaces were determined by a computer assisted method for each category of vessels in both 
LNG groups and the control group (Fig. 7). Immature, partially mature and mature vessels were smaller in short-
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term LNG users when compared with the control group (P < 0.0001). In contrast, larger vessels were observed 
in long-term LNG users, compared with the short-term LNG and control group (P < 0.0001). However, the 
proportion of vessels coated with pericytes increased progressively with time, indicating a trend towards a 
normalization of vessel structure. 
DISCUSSION 
Characteristics of endometrial vessels have not been thoroughly documented in women with short- or long-term 
exposure to LNG-IUS. 
LNG-IUS is an intrauterine contraceptive system, also licensed for the treatment of menorrhagia. The system 
increases apoptosis of the endometrial glands (Maruo et al., 2001) and promotes decidualization of the stroma 
(Silverberg et al., 1986). It reduces menstrual blood loss (Andersson and Rybo, 1990; Gupta et al., 2006) and its 
efficacy in the medical management of dysfunctional uterine bleeding is similar to that of endometrial resection 
(Gupta et al., 2006). Despite this beneficial effect on menstrual blood loss, compliance is hampered because of 
the initial troublesome side effect of breakthrough bleeding commonly seen during the first 1-6 months after 
insertion of the LNG-IUS (Lahteenmaki et al., 1998). 
Several factors contribute to BTB and their down- or up-regulation is a determinant for activation and 
maintenance of bleeding. Progesterone receptor (PR) and estrogen receptors (ER) expression is dramatically 
reduced in epithelial and stromal cells of LNG-IUS users endometrium (Zhu et al., 1999; Jones and Critchley, 
2000; Galant et al., 2004; Vereide et al., 2006). Our immunohistochemical study of PR expression also showed a 
significant down-regulation in short- and long-term LNG groups compared to a control group (data not shown). 
Our findings are thus in accordance with the previous studies. The decreased levels of PR may contribute to the 
contraceptive efficacy of this type of IUS but also to LNG-IUS-induced irregular bleeding. Vessel structure and 
integrity are indeed altered by progestin use, with changes in the shape, dilatation, the basement membrane 
components and pericyte support of vessels (Hickey et al., 2000; Hickey and Fraser, 2003). Perivascular cells 
and, in particular, pericytes provide structural stability and play a key role in blood vessel maturation during 
angiogenesis (Hanahan, 1997; Kohnen et al., 2000; Carmeliet, 2004). It has been proposed that, in women with 
BTB, there is an increased endometrial vascular fragility, leading to increased susceptibility to damage and 
rupture (Hickey et al., 2000). This concept is supported by the finding that pericytes are reduced around 
microvessels in the endometrium of women using progestin-only contraception who suffer from BTB compared 
with those without BTB (Rogers et al., 2000). 
Changes in vessel density with the associated decrease in the stromal support have also been hypothesized to 
contribute to vascular fragility and BTB (Hickey et al., 2000; Rogers et al., 2000; Jondet et al., 2005). Finally, a 
decreased expression of myosin has been documented in arterioles of women suffering from menorrhagia 
(Abberton et al., 1999; Girling and Rogers, 2005). This decreased vascular smooth muscle cells (VSMCs) 
differentiation results in a lack of contractile activity and could participate to the pathogenesis of BTB. 
Figure 5: Proportion of vessel number/mm2 in short-term LNG group (n = 8) and long-term LNG group (n= 11) 
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Figure 6: Relative vasculature area and percentage of each vessel category. (A) Relative vasculature area 
defined as the ratio between the vessel surface to total tissue area, in endometrium, in short-term LNG group 
(n=8) and long-term LNG group (n=11) compared with control group (n = 10) (**P < 0.001; ***P < 0.0001). 
(B) Percentage of each vessel category in control group, short-term LNG group and long-term LNG group. 
 
Figure 7: Mean vessel surfaces (µm2) were determined by computer assisted method for each category of vessels 
in short-term LNG group (n = 8), long-term LNG group (n= 11) and the control group (n = 10) (***P < 0.0001) 
 
In the present study, we analyzed the vasculature of endometrium under the influence of LNG-IUS for a short or 
a long period of time. Endometrial angiogenesis in LNG users results indeed in an extensive network of small 
naked or incompletely αSMA-coated vessels. Short-term LNG-IUS use was associated with a dramatic increase 
in the number of small naked and partially αSMA-coated vessels/mm2 (respectively, 11.5 and 6 times). The total 
tissue area occupied by these vessels was also considerably increased (respectively, 6 and 2.5 times). Altogether, 
our quantitative data provide a rationale for the excessive bleeding and spotting documented in these patients. 
Our data are in accordance with the observation of McGavigan et al. (2003) who have shown an increase in 
blood vessel density after a short-term exposure to LNG-IUS (McGavigan et al., 2003). 
In this study, long-term LNG use was associated with a significant decrease in the number of naked vessels in 
comparison with short-term LNG use. The relative vascular area of immature naked vessels was also reduced, 
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whereas that of mature vessels was increased in comparison with short-term users. Despite this progressive trend 
towards normalization of vessel structure, all vessels became larger after long-term use. This may also contribute 
to explain the unwanted BTB that may persist in some women, even after prolonged exposure. 
Hague et al. (2002) also previously showed an enhanced vascular density in long-term LNG users (Hague et al., 
2002), but did not discriminate between vessel types. Other studies have demonstrated changes similar to those 
described in our study in endometrium of women subcutaneously implanted with Norplant (Rogers et al., 1993; 
Hickey et al., 1999). An increase in total endometrial vessel density and an increase of negative αSMA vessels 
were described by Rogers et al. (1993; 2000). These congruent data strongly suggest that the vascular changes 
observed in our analysis can be attributed to the progestin present in the LNG-IUS rather than to an IUD effect. 
Indeed, copper IUDs classically do not elicit the histological changes described here and in Norplant users 
(Sheppard, 1987). 
Jondet et al. (2005) found a reduction of microvessel number with a concomitant dilatation in LNG-IUS users. 
They failed to discriminate maturation between vessel types which appears in this study to be a key parameter to 
attempt to correlate blood vessel changes with clinical features of bleeding. Angiogenesis in the endometrium 
involves the development of arterioles and elaboration of a capillary network. These events of maturation of 
arterioles involve a regulated VSMC differentiation, i.e. reduced by progestin. In endometrium of menorrhagic 
women, MHC expression was found to be reduced in VSMC of spiral arterioles. (Abberton et al.,1999). In this 
study, in each group, ~70% of all αSMA positive vessels also expressed the contractile myosin suggesting that 
changes in the contractile phenotypes are not responsible for the increased bleeding of these women. 
Altogether, our results show that LNG exposition leads to (i) a rapid increase of the number and area of sections 
of fragile naked vessels, (ii) the formation of smaller vessels after 1-3 months of treatment for all vessel 
categories and (iii) the enlargement of naked, partially mature and mature vessels after long-time exposure. 
These data support the clinical use of strategies that may minimize vascular morphology changes. Recently, 
Critchley et al. (2006) proposed an intermittent antiprogestin treatment during the first 3 months coincident with 
the highest bleeding and vascular fragility. Future approaches should be considered to limit these effects of 
progestogen on the endometrial blood vessel remodelling. 
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